CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling

Nature

Volumn 409, Issue 6818, 2001, Pages 349-354

  Irie Sasaki, Junko ^a,b   Sasaki, Takehiko ^a,b   Matsumoto, Wataru ^c   Opavsky, Anne ^d   Cheng, Mary ^a   Welstead, Grant ^a   Griffiths, Emily ^a   Krawczyk, Connie ^a   Richardson, Christopher D ^a   Aitken, Karen ^d   Iscove, Norman ^e   Koretzky, Gary ^f   Johnson, Pauline ^g   Liu, Peter ^d   Rothstein, David M ^c   Penninger, Josef M ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CYTOKINE RECEPTOR; ERYTHROPOIETIN; GROWTH FACTOR; JANUS KINASE; STAT PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; GENETIC TRANSCRIPTION; HEMATOPOIESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD45; BINDING SITES; CELL LINE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HEMATOPOIESIS; INTERLEUKIN-3; JANUS KINASE 2; MAST CELLS; MICE; MILK PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TYROSINE;

JANUS;

EID: 0035905767     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35053086     Document Type: Article

References (27)

1. From form to function: Signaling by protein tyrosine phosphatases
2. - exon6 protein tyrosine phosphatase-deficient mice
3. - thymocytes, and B cell maturation
4. CD45: An emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development
5. The leukocyte common antigen family
6. Regulation of proliferation, differentiation and survival by the IL-3/IL-5/GM-CSF receptor family
7. Jaks and STATs: Biological implications
8. Transcriptional regulation of the cyclin D1 promoter by STAT5: Its involvement in cytokine-dependent growth of hematopoietic cells
9. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation
10. Characterization of recombinant CD45 cytoplasmic domain proteins. Evidence for intramolecular and intermolecular interactions
11. Distinct isoforms of the CD45 protein-tyrosine phosphatase differentially regulate interleukin 2 secretion and activation signal pathways involving Vav in T cells
12. Cytokine receptor signalling
13. Antiproliferative action of interferon-α requires components of T-cell-receptor signalling
14. Jak2 is essential for signaling through a variety of cytokine receptors
15. SOCS3 is essential in the regulation of fetal liver erythropoiesis
16. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses
17. Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon
18. The Jak-Stat pathway in normal and perturbed hematopoiesis
19. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop
20. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals
21. Immunophenotype and clinical characteristics of CD45-negative and CD45-positive childhood acute lymphoblastic leukemia
22. Hodgkin's disease presenting as a solitary bone tumor. A report of four cases and review of the literature
23. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease
24. Insulin induces tyrosine phosphorylation of JAK2 in insulin-sensitive tissues of the intact rat
25. Transgenic mice deficient in the LAR, protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis
26. SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival
27. Abrogation of interleukin-3 dependence of myeloid cells by the v-src oncogene requires SH2 and SH3 domains which specify activation of STATs